Differential expression of glutamate receptors by the dopaminergic neurons of the primate striatum

被引:20
作者
Betarbet, R [1 ]
Greenamyre, JT
机构
[1] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA
[3] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30322 USA
关键词
striatum; dopaminergic cells; GluR2; NR1; MPTP; metabotropic receptors;
D O I
10.1006/exnr.1999.7154
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neostriatal neurons are targets of glutamatergic input from the cortex and thalamus. Glutamate receptors are abundantly, but differentially, expressed by the striatal neurons. We previously described the presence of dopaminergic cells intrinsic to the primate striatum that increase in number following MPTP treatment. In this study we have used double-label immunocytochemistry to analyze the expression of the glutamate receptor subunits GluR1, GluR2/3, NR1, mGluR1, and mGluR5 in the dopaminergic cells of the striatum. Our results show that 75% of these cells express GluR1 while 25% of them express NR1. They do not express GluR2/3 or the group 1 metabotropic receptors. Our results suggest that this potentially important population of cells expresses only calcium-permeable ionotropic glutamate receptors. We speculate that glutamate may play a role in regulating the number of these dopaminergic neurons after MPTP treatment and may also influence their ability to release dopamine. (C) 1999 Academic Press.
引用
收藏
页码:401 / 408
页数:8
相关论文
共 62 条
[1]  
ABE T, 1992, J BIOL CHEM, V267, P13361
[2]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[3]   Functional AMPA/kainate receptors in human embryonic and foetal central nervous system [J].
Bardoul, M ;
Levallois, C ;
König, N .
JOURNAL OF CHEMICAL NEUROANATOMY, 1998, 14 (02) :79-85
[4]   MECHANISMS OF EXCITOTOXICITY IN NEUROLOGIC DISEASES [J].
BEAL, MF .
FASEB JOURNAL, 1992, 6 (15) :3338-3344
[5]  
BEAR MF, 1991, ANN NY ACAD SCI, V627, P42
[6]  
Bernard V, 1997, J NEUROSCI, V17, P819
[7]  
Betarbet R, 1997, J NEUROSCI, V17, P6761
[8]  
Blandini F, 1996, FUNCT NEUROL, V11, P3
[9]  
Boulter J, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p60A
[10]  
Camón L, 1998, J NEUROSCI RES, V51, P339, DOI 10.1002/(SICI)1097-4547(19980201)51:3<339::AID-JNR7>3.3.CO